Automation, consolidation, and integration in autoimmune diagnostics

Over the past two decades, we have witnessed an extraordinary change in autoimmune diagnostics, characterized by the progressive evolution of analytical technologies, the availability of new tests, and the explosive growth of molecular biology and proteomics. Aside from these huge improvements, organizational changes have also occurred which brought about a more modern vision of the autoimmune laboratory. The introduction of automation (for harmonization of testing, reduction of human error, reduction of handling steps, increase of productivity, decrease of turnaround time, improvement of safety), consolidation (combining different analytical technologies or strategies on one instrument or on one group of connected instruments) and integration (linking analytical instruments or group of instruments with pre- and post-analytical devices) opened a new era in immunodiagnostics. In this article, we review the most important changes that have occurred in autoimmune diagnostics and present some models related to the introduction of automation in the autoimmunology laboratory, such as automated indirect immunofluorescence and changes in the two-step strategy for detection of autoantibodies; automated monoplex immunoassays and reduction of turnaround time; and automated multiplex immunoassays for autoantibody profiling.

[1]  Liron Pantanowitz,et al.  Telecytology: Clinical applications, current challenges, and future benefits , 2011, Journal of pathology informatics.

[2]  A. Wu.  A selected history and future of immunoassay development and applications in clinical chemistry. , 2006, Clinica chimica acta; international journal of clinical chemistry.

[3]  R. Nakamura,et al.  Factors influencing changes in the clinical immunology laboratory. , 1994, Clinical chemistry.

[4]  N. Bizzaro,et al.  Detecting multiple autoantibodies to diagnose autoimmune co-morbidity (multiple autoimmune syndromes and overlap syndromes): a challenge for the autoimmunologist , 2013, Immunologic research.

[5]  Nicola Bizzaro,et al.  The clinical autoimmunologist and the laboratory autoimmunologist: the two sides of the coin. , 2012, Autoimmunity reviews.

[6]  Y. Shoenfeld,et al.  Autoantibodies 2015: From diagnostic biomarkers toward prediction, prognosis and prevention. , 2015, Autoimmunity reviews.

[7]  Torsten Witte,et al.  International recommendations for the assessment of autoantibodies to cellular antigens referred to as anti-nuclear antibodies , 2013, Annals of the rheumatic diseases.

[8]  Nicola Bizzaro,et al.  Current state of diagnostic technologies in the autoimmunology laboratory , 2012, Clinical chemistry and laboratory medicine.

[9]  Nicola Bizzaro,et al.  Automated antinuclear immunofluorescence antibody screening: a comparative study of six computer-aided diagnostic systems. , 2014, Autoimmunity reviews.

[10]  A. Wiik,et al.  Missing links in high quality diagnostics of inflammatory systemic rheumatic diseases , 2012, Autoimmunity Highlights.

[11]  R. Hamilton.  The clinical immunology laboratory of the future. , 1994, Clinical chemistry.

[12]  G. Iannello,et al.  The classification of Crithidia luciliae immunofluorescence test (CLIFT) using a novel automated system , 2014, Arthritis Research & Therapy.

[13]  Charles D Hawker,et al.  Laboratory automation: total and subtotal. , 2007, Clinics in laboratory medicine.

[14]  Bin Yang,et al.  Novel method for ANA quantitation using IIF imaging system. , 2014, Journal of immunological methods.

[15]  M. Fritzler,et al.  Clinical and Serological Analysis of Patients with Positive Anticyclic Citrullinated Peptide Antibodies Referred Through a Rheumatology Central Triage System , 2015, The Journal of Rheumatology.

[16]  José M González-Buitrago,et al.  Present and future of the autoimmunity laboratory. , 2006, Clinica chimica acta; international journal of clinical chemistry.

[17]  W. Verboeket-van de Venne,et al.  Reflective testing: adding value to laboratory testing , 2012, Clinical chemistry and laboratory medicine.

[18]  E. Pearce.  Diagnosis and management of thyrotoxicosis , 2006, BMJ : British Medical Journal.

[19]  Nicola Bizzaro,et al.  The laboratory approach to the diagnosis of autoimmune diseases: is it time to change? , 2007, Autoimmunity reviews.

[20]  Elizabeth A. Krupinski,et al.  American Telemedicine Association clinical guidelines for telepathology , 2014, Journal of pathology informatics.

[21]  N. Bizzaro,et al.  Autoimmune diagnostics: the technology, the strategy and the clinical governance , 2015, Immunologic research.

[22]  J. Holle,et al.  Twenty-eight years with antineutrophil cytoplasmic antibodies (ANCA): how to test for ANCA — evidence-based immunology? , 2010, Autoimmunity Highlights.

[23]  J. Anaya,et al.  Autoimmune diseases in the intensive care unit. An update. , 2013, Autoimmunity reviews.

[24]  L. Bungener,et al.  Performance of two strategies for urgent ANCA and anti-GBM analysis in vasculitis. , 2014, European journal of internal medicine.

[25]  M. Cook,et al.  Updated assessment of the prevalence, spectrum and case definition of autoimmune disease. , 2012, Autoimmunity reviews.

[26]  Marco Pradella,et al.  Guidelines for the laboratory use of autoantibody tests in the diagnosis and monitoring of autoimmune rheumatic diseases. , 2002, American journal of clinical pathology.

[27]  M J Fritzler,et al.  Advances and Applications of Multiplexed Diagnostic Technologies in Autoimmune Diseases , 2006, Lupus.

[28]  J. Bock,et al.  The new era of automated immunoassay. , 2000, American journal of clinical pathology.

[29]  G E Hoffmann,et al.  Concepts for the third generation of laboratory systems. , 1998, Clinica chimica acta; international journal of clinical chemistry.

[30]  N. Woodford,et al.  Sudden unexpected death in the setting of undiagnosed Graves’ disease , 2014, Forensic Science, Medicine, and Pathology.

[31]  S. Holding,et al.  Clinical evaluation of the BioPlex 2200 Celiac IgA and IgG Kits - a novel multiplex screen incorporating an integral check for IgA deficiency. , 2014, Journal of immunological methods.

[32]  L. Barisoni,et al.  Catastrophic antiphospholipid syndrome with concurrent thrombotic and hemorrhagic manifestations , 2013, Lupus.

[33]  Renato Tozzoli,et al.  Automation in indirect immunofluorescence testing: a new step in the evolution of the autoimmunology laboratory , 2012, Autoimmunity Highlights.

[34]  Pierre Bongrand,et al.  Original Approach for Automated Quantification of Antinuclear Autoantibodies by Indirect Immunofluorescence , 2013, Clinical & developmental immunology.

[35]  J. C. Cohen Tervaert,et al.  From ANA to ENA: how to proceed? , 2006, Autoimmunity reviews.

[36]  C. Bonroy,et al.  Automated indirect immunofluorescence microscopy enables the implementation of a quantitative internal quality control system for anti-nuclear antibody (ANA) analysis , 2014, Clinical chemistry and laboratory medicine.

[37]  David A Armbruster,et al.  Clinical Chemistry Laboratory Automation in the 21st Century - Amat Victoria curam (Victory loves careful preparation). , 2014, The Clinical biochemist. Reviews.

[38]  Renato Tozzoli,et al.  Recent advances in diagnostic technologies and their impact in autoimmune diseases. , 2007, Autoimmunity reviews.

[39]  D. Villalta,et al.  Autoantibody profiling of patients with antiphospholipid syndrome using an automated multiplexed immunoassay system. , 2014, Autoimmunity reviews.

[40]  Mario Plebani,et al.  Harmonization in laboratory medicine: the complete picture , 2013, Clinical chemistry and laboratory medicine.

[41]  K. Konstantinov,et al.  Detection of autoantibodies in a point-of-care rheumatology setting , 2013, Autoimmunity Highlights.